Josh Johnston, OD, FAAO, evaluates the nuances integral to success with new technology for premium cataract surgery. He is the clinical and residency director at Georgia Eye Partners in Atlanta. Johnston reports he is a consultant to Alcon, Allergan, Bio-Tissue, Johnson & Johnson Vision and Shire.
A refractive surprise after cataract surgery is a dreaded outcome for the surgeon and, more importantly, a satisfaction killer for patients. No matter what type of…
We know that today’s cataract surgery is truly refractive cataract surgery. As such, patients expect refractive type outcomes after the procedure. Therefore, more…
The sheer numbers provide much of the obvious evidence of why optometrists need to be involved in the comanagement of cataract surgery. Currently, about 3 million…
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.